The report states Q2 revenue grew 33.7% to ₹1,469 crore and net profit rose 39.9% to ₹221 crore, with Ebitda margin improving to 25.3% from 21%.
Read this note →Global Health Limited
NSE MEDANTA BSE 543654 INE474Q01031
0 filings · 0 analysed
1,427.10
+15.20%
over 6 months
-
Daily Market Mirror 2026 11 04
The report states Q2 revenue grew 33.7% to ₹1,469 crore and net profit rose 39.9% to ₹221 crore, with Ebitda margin improving to 25.3% from 21%.
-
The report expects Global Health sales to grow 17.5% YoY and PAT to grow 25.4% YoY in 2QFY27.
-
The note reports Global Health acquired a Rs 166 crore land parcel in Ghaziabad with potential for a 350-bed hospital.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
What the desks said
The report expects Global Health sales to grow 17.5% YoY and PAT to grow 25.4% YoY in 2QFY27.
Read this note →The note reports Global Health acquired a Rs 166 crore land parcel in Ghaziabad with potential for a 350-bed hospital.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief